CONTRAINDICATIONS SECTION.
CONTRAINDICATIONS. This product is contraindicated in patients with known hypersensitivity to any of the ingredients.
Citing DrugCentral © 2024. License
ADVERSE REACTIONS SECTION.
ADVERSE REACTIONS. Allergic sensitizations have been reported following oral administration of folic acid.Consult your physician immediately if adverse side effects occur.
Citing DrugCentral © 2024. License
DESCRIPTION SECTION.
DESCRIPTION. Dialyvite is prescription folic acid supplement with additional nutrients for kidney dialysis patients. Dialyvite is small, round, light pink, clear-coated tablet, with debossed H on one side.Each tablet contains:Folic Acid.....1 mgVitamin (Ascorbic Acid).....100 mgThiamine (Thiamine Mononitrate).....1.5 mgRiboflavin.....1.7 mgNiacinamide.....20 mgVitamin B6 (Pyridoxine HCl).....10 mgVitamin B12 (Methylcobalamin).....6 mcgBiotin.....300 mcgPantothenic Acid (Calcium Pantothenate).....10 mgInactive ingredients:Microcrystalline Cellulose, Croscarmellose Sodium, Mono- and Diglycerides, Starch, Hypromellose, Polyethylene Glycol, Calcium Stearate, Carmine (color).
Citing DrugCentral © 2024. License
DOSAGE & ADMINISTRATION SECTION.
DOSAGE AND ADMINISTRATION. Take one tablet per day or as directed by your physician, orally.
Citing DrugCentral © 2024. License
HOW SUPPLIED SECTION.
HOW SUPPLIED. Product: 17856-0010NDC: 17856-0010-4 TABLET, COATED in DOSE PACK.
Citing DrugCentral © 2024. License
INDICATIONS & USAGE SECTION.
INDICATIONS AND USAGE. Dialyvite is prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients.
Citing DrugCentral © 2024. License
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
DIALYVITE (ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID) TABLET, COATED. Label Image.
Citing DrugCentral © 2024. License
PRECAUTIONS SECTION.
PRECAUTIONS. Folic acid supplementation may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations progress.Keep out of reach of children.
Citing DrugCentral © 2024. License